Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia
- PMID: 22194589
- PMCID: PMC7094498
- DOI: 10.1378/chest.11-1446
Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia
Abstract
Background: The inflammatory response in community-acquired pneumonia (CAP) depends on the host and on the challenge of the causal microorganism. Here, we analyze the patterns of inflammatory cytokines, procalcitonin (PCT), and C-reactive protein (CRP) in order to determine their diagnostic value.
Methods: This was a prospective study of 658 patients admitted with CAP. PCT and CRP were analyzed by immunoluminometric and immunoturbidimetric assays. Cytokines (tumor necrosis factor-α [TNF-α], IL-1β, IL-6, IL-8, and IL-10) were measured using enzyme immunoassay.
Results: The lowest medians of CRP, PCT, TNF-α, and IL-6 were found in CAP of unknown cause, and the highest were found in patients with positive blood cultures. Different cytokine profiles and biomarkers were found depending on cause: atypical bacteria (lower PCT and IL-6), viruses (lower PCT and higher IL-10), Enterobacteriaceae (higher IL-8), Streptococcus pneumoniae (high PCT), and Legionella pneumophila (higher CRP and TNF-α). PCT ≥ 0.36 mg/dL to predict positive blood cultures showed sensitivity of 85%, specificity of 42%, and negative predictive value (NPV) of 98%, whereas a cutoff of ≤ 0.5 mg/dL to predict viruses or atypicals vs bacteria showed sensitivity of 89%/81%, specificity of 68%/68%, positive predictive value of 12%/22%, and NPV of 99%/97%. In a multivariate Euclidean distance model, the lowest inflammatory expression was found in unknown cause and the highest was found in L pneumophila, S pneumoniae, and Enterobacteriaceae. Atypical bacteria exhibit an inflammatory pattern closer to that of viruses.
Conclusions: Different inflammatory patterns elicited by different microorganisms may provide a useful tool for diagnosis. Recognizing these patterns provides additional information that may facilitate a broader understanding of host inflammatory response to microorganisms.
Figures

Similar articles
-
The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis.Eur Rev Med Pharmacol Sci. 2013 Dec;17(24):3329-33. Eur Rev Med Pharmacol Sci. 2013. PMID: 24379064
-
Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?J Crit Care. 2013 Dec;28(6):970-4. doi: 10.1016/j.jcrc.2013.04.016. J Crit Care. 2013. PMID: 24216331
-
Procalcitonin in children admitted to hospital with community acquired pneumonia.Arch Dis Child. 2001 Apr;84(4):332-6. doi: 10.1136/adc.84.4.332. Arch Dis Child. 2001. PMID: 11259234 Free PMC article.
-
Biomarkers and community-acquired pneumonia: tailoring management with biological data.Semin Respir Crit Care Med. 2012 Jun;33(3):266-71. doi: 10.1055/s-0032-1315638. Epub 2012 Jun 20. Semin Respir Crit Care Med. 2012. PMID: 22718212 Review.
-
Biomarkers in community-acquired pneumonia.Expert Rev Respir Med. 2012 Apr;6(2):203-14. doi: 10.1586/ers.12.6. Expert Rev Respir Med. 2012. PMID: 22455492 Review.
Cited by
-
Biomarkers of Community-Acquired Pneumonia: A Key to Disease Diagnosis and Management.Biomed Res Int. 2019 Apr 30;2019:1701276. doi: 10.1155/2019/1701276. eCollection 2019. Biomed Res Int. 2019. PMID: 31183362 Free PMC article. Review.
-
N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia: A randomized controlled trial.Medicine (Baltimore). 2018 Nov;97(45):e13087. doi: 10.1097/MD.0000000000013087. Medicine (Baltimore). 2018. PMID: 30407312 Free PMC article. Clinical Trial.
-
Year in review 2012: Critical Care--respiratory infections.Crit Care. 2013 Nov 22;17(6):251. doi: 10.1186/cc12773. Crit Care. 2013. PMID: 24438847 Free PMC article. Review.
-
Interpretation of C-reactive protein concentrations in critically ill patients.Biomed Res Int. 2013;2013:124021. doi: 10.1155/2013/124021. Epub 2013 Oct 28. Biomed Res Int. 2013. PMID: 24286072 Free PMC article. Review.
-
Predicting treatment failure in patients with community acquired pneumonia: a case-control study.Respir Res. 2014 Jul 5;15(1):75. doi: 10.1186/1465-9921-15-75. Respir Res. 2014. PMID: 24996572 Free PMC article.
References
-
- Deng JC, Standiford TJ. The systemic response to lung infection. Clin Chest Med. 2005;26(1):1–9. - PubMed
-
- Bals R, Hiemstra PS. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur Respir J. 2004;23(2):327–333. - PubMed
-
- Hedlund J, Hansson LO. Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis. Infection. 2000;28(2):68–73. - PubMed
-
- Menéndez R, Martínez R, Reyes S. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax. 2009;64(7):587–591. - PubMed
-
- Woodhead M. The European vision of community-acquired pneumonia. Semin Respir Crit Care Med. 2009;30(2):136–145. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous